Successful ECMO support for cardiogenic shock induced by immune checkpoint inhibitor-associated myocarditis: a case report and literature review
Our analysis demonstrates ECMO's potential as a bridge-to-recovery strategy for severe ICI-associated myocarditis with cardiogenic shock. The observed survival rate of 69.23% supports its judicious use in conjunction with prompt immunosuppression. Prospective studies are warranted to optimize ECMO initiation criteria, duration, and combination strategies with other circulatory support modalities.
Authors
- Huaqing Shu
- Yongxiang Jiang (ORCID: https://orcid.org/0000-0001-5794-369X)
- Yuan Yin (ORCID: https://orcid.org/0000-0003-3359-4282)
- You Shang (ORCID: https://orcid.org/0000-0003-4097-6131)
- Ruiting Li (ORCID: https://orcid.org/0000-0001-8041-1050)
- Yujing Zhang (ORCID: https://orcid.org/0000-0003-4425-5366)
- Sheng‐Wen Sun
Institutions
- Wuhan Union Hospital (CN)
- Union Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-12-08
- DOI
- https://doi.org/10.3389/fimmu.2025.1646040
- Citations
- 1
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China